Technology · 09/10/2026

European Medicines Agency Approves Modification to Paediatric Investigation Plan for Aimovig and Erenumab

The European Medicines Agency has issued an opinion and decision on a Paediatric Investigation Plan (PIP) for Aimovig and Erenumab, a therapeutic area of surgical and medical procedures, following a modification application to the agreed PIP.